Gastrointestinal (GI), liver, and pancreaticobiliary diseases, in addition to the high health care utilization and spending, account for a significant proportion of disability and death in Iran. We aimed to assess the incidence of in-hospital mortality for the total GI, liver, and pancreaticobiliary diseases in all hospitals in Kerman, IRAN.

In a cross-sectional study from May 2017 to April 2018, we collected daily in-hospital death records due to GI, liver, and pancreaticobiliary diseases in all hospitals in Kerman city. GI and liver diseases were classified into three main categories: 1.Nonmalignant gastrointestinal diseases 2.Nonmalignant Liver and Pancreatobiliry diseases 3.GI, liver, and pancreaticobiliary malignancies. All data were analyzed using the Statistical Package for the Social Sciences (SPSS), version 22 (IBM).

Of 3427 in-hospital mortality, 269 (7.84%) deaths were due to GI and liver and pancreaticobiliary diseases that 82 (30.48%) were related to nonmalignant GI disorders, 92 (34.20%) nonmalignant liver and pancreaticobiliary diseases, and 95 (35.31%) were associated with GI, liver and pancreaticobiliary malignancies. Most patients were male (62.08%) and the more common age was between 60-80 years (40.5%). GI bleeding occurred in 158 (58.73%) patients and variceal bleeding was the most common cause (28.48%). Additionally, cirrhosis was reported in 41 out of 92 (44.56%), and hepatitis B infection was the most common cause of cirrhosis among 17 out of 41 (41.46%).

Our results show that gastric, colorectal, and pancreatic cancers and cirrhosis due to HBV were the most common causes of mortality associated with gastrointestinal, liver, and pancreaticobiliary diseases in the hospitals of Kerman.